Januvia sitagliptin: Additional Phase III data
Additional data from a 24-week, double-blind, placebo-controlled Phase III trial in 1,091 patients showed that
Gathering data...
Additional data from a 24-week, double-blind, placebo-controlled Phase III trial in 1,091 patients showed that